Rivaroxaban

A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.

Year introduced: 2016 (2005)

PubMed search builder options

Subheadings:

Restrict to MeSH Major Topic.

Do not include MeSH terms found below this term in the MeSH hierarchy.

Tree Number(s): D02.886.778.727, D03.383.533.640.713, D03.383.903.727

MeSH Unique ID: D000069552

Registry Number: 9NDF7JZ4M3

Entry Terms:

• 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
• BAY 59-7939
• BAY 597939
• BAY 59 7939
• Xarelto

Pharmacologic Action:

• Factor Xa Inhibitors

All MeSH Categories
Chemicals and Drugs Category
Organic Chemicals
Sulfur Compounds
Thiophenes
Rivaroxaban

All MeSH Categories
Chemicals and Drugs Category
Heterocyclic Compounds
Heterocyclic Compounds, 1-Ring
Oxazines
Morpholines
Rivaroxaban

All MeSH Categories
Chemicals and Drugs Category
Heterocyclic Compounds
Heterocyclic Compounds, 1-Ring
Thiophenes
Rivaroxaban